Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1131-1140 of 2932 for cancer

Edit search filters
  1. A Study Of The Safety And Effectiveness Of Methylene Blue MMX® Modified Release Tablets Administered To Subjects Undergoing Screening Or Surveillance Colonoscopy

    Rochester, MN

  2. A Study Of Prehabilitation In Patients With Multiple Myeloma Receiving CAR-T Therapy

    Rochester, MN

  3. Chemotherapy For The Treatment Of Patients With Newly Diagnosed Very Low-Risk And Low Risk Fusion Negative Rhabdomyosarcoma

    Rochester, MN

  4. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma

    Rochester, MN

  5. A Study To Determine The Effects Of A Mechanical Device To Treat Swelling Of The Face And Neck Following Treatment For Cancer.

    Scottsdale/Phoenix, AZ

  6. A Study Of MRI-Targeted Biopsy Compared To Standard Ultrasound Guided Biopsy For The Diagnosis Of Prostate Cancer

    Rochester, MN

  7. Retifanlimab And Epacadostat In Combination With Radiation And Bevacizumab In Patients With Recurrent Gliomas

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Embolization Before Ablation Of Renal Cell Carcinoma (EMBARC)"

    Rochester, MN

  9. Study Of TBio-6517, Given Intratumorally, Alone Or In Combination With Pembrolizumab, In Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. NKX101, Intravenous Allogeneic CAR NK Cells, In Adults With AML Or MDS

    Jacksonville, FL

.

Mayo Clinic Footer